These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 35530147)

  • 1. Optical substrates for drug-metabolizing enzymes: Recent advances and future perspectives.
    Jin Q; Wu J; Wu Y; Li H; Finel M; Wang D; Ge G
    Acta Pharm Sin B; 2022 Mar; 12(3):1068-1099. PubMed ID: 35530147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.
    Rushmore TH; Kong AN
    Curr Drug Metab; 2002 Oct; 3(5):481-90. PubMed ID: 12369894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INTEDE: interactome of drug-metabolizing enzymes.
    Yin J; Li F; Zhou Y; Mou M; Lu Y; Chen K; Xue J; Luo Y; Fu J; He X; Gao J; Zeng S; Yu L; Zhu F
    Nucleic Acids Res; 2021 Jan; 49(D1):D1233-D1243. PubMed ID: 33045737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review.
    Raju B; Choudhary S; Narendra G; Verma H; Silakari O
    Drug Metab Rev; 2021 Feb; 53(1):45-75. PubMed ID: 33535824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Systems Biology of Drug Metabolizing Enzymes and Transporters: Relevance to Quantitative Systems Pharmacology.
    Nigam SK; Bush KT; Bhatnagar V; Poloyac SM; Momper JD
    Clin Pharmacol Ther; 2020 Jul; 108(1):40-53. PubMed ID: 32119114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schisandra chinensis regulates drug metabolizing enzymes and drug transporters via activation of Nrf2-mediated signaling pathway.
    He JL; Zhou ZW; Yin JJ; He CQ; Zhou SF; Yu Y
    Drug Des Devel Ther; 2015; 9():127-46. PubMed ID: 25552902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liver diseases on drug-metabolizing enzymes: implications for drug fate alterations and nano-therapeutic openings.
    Lu L; Shi J; Li Q; Peng X; Dong L; Li Y; Dai P; Wang Y; Guo E; Zhou F; Liu Z
    Curr Med Chem; 2014; 21(22):2522-41. PubMed ID: 24358976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in drug metabolism and pharmacogenetics research in Australia.
    Mackenzie PI; Somogyi AA; Miners JO
    Pharmacol Res; 2017 Feb; 116():7-19. PubMed ID: 27956261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of pharmacokinetic studies on herbal drug Fuzi: Implications for Fuzi as personalized medicine.
    Wu JJ; Guo ZZ; Zhu YF; Huang ZJ; Gong X; Li YH; Son WJ; Li XY; Lou YM; Zhu LJ; Lu LL; Liu ZQ; Liu L
    Phytomedicine; 2018 May; 44():187-203. PubMed ID: 29526584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it.
    Verma H; Singh Bahia M; Choudhary S; Kumar Singh P; Silakari O
    Drug Metab Rev; 2019 May; 51(2):196-223. PubMed ID: 31203662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of xenobiotic receptors, transporters, and drug metabolizing enzymes by oxycodone.
    Hassan HE; Myers AL; Lee IJ; Mason CW; Wang D; Sinz MW; Wang H; Eddington ND
    Drug Metab Dispos; 2013 May; 41(5):1060-9. PubMed ID: 23439660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate.
    Yu KN; Kang SY; Hong S; Lee MY
    Arch Toxicol; 2018 Aug; 92(8):2501-2516. PubMed ID: 29974144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulation of Differentially Expressed Drug-Metabolizing Enzymes in Cancer.
    Wang J; Yu L; Jiang H; Zheng X; Zeng S
    Drug Metab Dispos; 2020 Sep; 48(9):759-768. PubMed ID: 32601104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review.
    Korashy HM; Elbekai RH; El-Kadi AO
    Xenobiotica; 2004 Jan; 34(1):1-29. PubMed ID: 14742134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacogenetics of drug metabolizing enzymes in the Lebanese population.
    Ossaily S; Zgheib NK
    Drug Metabol Drug Interact; 2014; 29(2):81-90. PubMed ID: 24413215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate.
    Kang SY; Yu KN; Joshi P; Lee MY
    Methods Mol Biol; 2020; 2089():191-207. PubMed ID: 31773656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.